NCT01563861
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
Not specified
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
1,466 public trials
175 recruiting studies
Lymphoma trial results
NCT01445379
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +31 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00036790
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +126 more
- Locations
-
- Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
NCT00001852
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +22 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01445522
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01517152
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +29 more
- Locations
-
- National Cancer Institute (NCI), 9000 Rockville Pike Bethesda, Maryland, United States
Completed
High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease
NCT01200329
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00013533
- Conditions
- ALL, AML, Bone Marrow Diseases, +21 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
NCT00049712
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
- Locations
-
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
NCT00003270
- Conditions
- Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +57 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States